Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Antiviral immune response against HTLV-1 invalidates T-SPOT.TB® results in patients with HTLV-1-positive rheumatic diseases

Autor: Masatoshi Kimura, Kunihiko Umekita, Chihiro Iwao, Katsumi Kawano, Yuki Hashikura, Yayoi Hashiba, Toshihiko Hidaka, Kenji Sugata, Yorifumi Satou, Taiga Miyazaki

Publikováno v: Frontiers in Immunology, Vol 15 (2024)

BackgroundT-SPOT.TB®, one of the screening tests for latent tuberculosis infection (LTBI), yields invalid results in human T-cell leukemia virus type 1 (HTLV-1)-positive patients with rheumatoid arthritis. However, the detailed mechanisms behind thi

Externí odkaz: https://doaj.org/article/7e85ff55ce1c4e358f80cfc84adf3c95

Comparing the diagnostic performance of QuantiFERON-TB Gold Plus with QFT-GIT, T-SPOT.TB and TST: a systematic review and meta-analysis.

Autor: Zhang, Yu¹ (AUTHOR), Zhou, Guozhong² (AUTHOR), Shi, Wei¹ (AUTHOR), Shi, Weili¹ (AUTHOR), Hu, Meijun¹ (AUTHOR), Kong, Defu¹ (AUTHOR), Long, Rong¹ (AUTHOR), He, Jian³ (AUTHOR), Chen, Nan¹ (AUTHOR) saint0728@163.com

Publikováno v: BMC Infectious Diseases. 1/20/2023, Vol. 23 Issue 1, p1-11. 11p.

Antiviral immune response against HTLV-1 invalidates T-SPOT.TB ^® results in patients with HTLV-1-positive rheumatic diseases.

Autor: Kimura M; Division of Respirology, Rheumatology, Infectious Diseases and Neurology, Department of Internal Medicine, University of Miyazaki, Miyazaki, Japan., Umekita K; Division of Respirology, Rheumatology, Infectious Diseases and Neurology, Department of Internal Medicine, University of Miyazaki, Miyazaki, Japan.; Clinical Laboratory, University of Miyazaki of Hospital, Miyazaki, Japan., Iwao C; Division of Respirology, Rheumatology, Infectious Diseases and Neurology, Department of Internal Medicine, University of Miyazaki, Miyazaki, Japan., Kawano K; Clinical Laboratory, University of Miyazaki of Hospital, Miyazaki, Japan., Hashikura Y; Clinical Laboratory, University of Miyazaki of Hospital, Miyazaki, Japan., Hashiba Y; Institute of Rheumatology, Miyazaki Zenjinkai Hospital, Miyazaki, Japan., Hidaka T; Institute of Rheumatology, Miyazaki Zenjinkai Hospital, Miyazaki, Japan., Sugata K; Division of Genomics and Transcriptomics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan., Satou Y; Division of Genomics and Transcriptomics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan., Miyazaki T; Division of Respirology, Rheumatology, Infectious Diseases and Neurology, Department of Internal Medicine, University of Miyazaki, Miyazaki, Japan.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Oct 29; Vol. 15, pp. 1480506. Date of Electronic Publication: 2024 Oct 29 (Print Publication: 2024).

Antiviral immune response against HTLV-1 invalidates T-SPOT.TB^® results in patients with HTLV-1-positive rheumatic diseases.

Autor: Kimura, Masatoshi, Umekita, Kunihiko, Iwao, Chihiro, Kawano, Katsumi, Hashikura, Yuki, Hashiba, Yayoi, Hidaka, Toshihiko, Sugata, Kenji, Satou, Yorifumi, Miyazaki, Taiga

Publikováno v: Frontiers in Immunology; 2024, p1-16, 16p